Laura Clague Standard Biotools Inc. (LAB) insider trading activity

LAB Quotes by TradingView

Laura Clague is Director of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 104,791 shares of LAB, which is worth approximately $209,582. The most recent transaction as insider was on Jun 14, 2023, when has been sold 26,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
0% 12M change
Total Value Held $209,582

Laura Clague Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Grant, award, or other acquisition
-
26,376 Added 20.11%
104,791 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
30,914 Added 28.28%
78,415 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
10,342 Added 17.88%
47,501 Common Stock
Feb 20 2021
BUY
Grant, award, or other acquisition
-
9,803 Added 20.87%
37,159 Common Stock

Also insider at

TVTX
Travere Therapeutics, Inc. Healthcare
Chief Financial Officer
GNSS
Genasys Inc. Technology
Director
LC

Laura Clague

Director
San Diego, CA

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LAB